Tritanrix-HepB/Hib

BIOLOGICAL4 trials

Sponsors

Sanofi Pasteur, a Sanofi Company, GlaxoSmithKline

Conditions

DiphtheriaHaemophilus Influenzae Type bHepatitis BInfections, StreptococcalPertussisStreptococcus PneumoniaeTetanus

Phase 3

Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

CompletedNCT00313911

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Haemophilus Influenzae Type b, Hepatitis B +2

Start: 2006-07-31End: 2008-02-29Updated: 2014-04-21

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age

CompletedNCT00814710

GlaxoSmithKlineInfections, Streptococcal, Streptococcus Pneumoniae

Start: 2009-03-07End: 2009-11-13Updated: 2020-01-03

Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.

CompletedNCT00829010

GlaxoSmithKlineInfections, Streptococcal

Start: 2009-02-17End: 2012-06-27Updated: 2018-08-17

Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A

CompletedNCT01175083

GlaxoSmithKlineInfections, Streptococcal

Start: 2011-06-01End: 2013-05-23Updated: 2019-06-06

Related Papers

Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials

Expert Review of Vaccines2020-11-273 citations

Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa.

2020-02-055 citations

Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial.

2017-06-016 citations

Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.

2017-05-013 citations

Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status.

2017-01-0114 citations

Randomized, Open-Label Study of the Impact of Age on Booster Responses to the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Children in India

Clinical and Vaccine Immunology2014-07-109 citations